Welcome to the
press page of Semalytix.

Learn more about our company and our technology.

For a disease-free future for everyone.

We believe in a disease-free future for all of humanity and create AI technology that uncovers unknown patient needs and generates the deepest possible understanding of how humans suffer from diseases. Through Artificial Intelligence we can learn from the global patient experience for the first time in full scale and provide patient-centric guidance for new therapies and to improve the quality of care for billions, one disease at a time.

We would like to get to know you.

We would like to invite you to get in touch with us. We are a tech company – but moreover, we are a bunch of people who deeply believe in a future without diseases. Therefore we work hard and passionately, but more importantly we would like to spread the word that our technology really can help our society.

We guide you to get a better understanding of us.

As our technology is not always easy to understand we invite you to talk with us. So please do not hesitate to reach out to us. We are looking forward to meeting you.

Your Press Team of Semalytix.

 

JannisJohannmeier

Jannis Johannmeier

Press Representative

Hi! I am looking forward to getting in touch with you!
jannis.johannmeier@semalytix.com | +49 172 5270504

Janik-Jaskolski_Semalytix-Cofounder

 

We envision a performance-driven healthcare system that uses data-driven real-world evidence generation methods to accurately measure and optimize real-world outcomes and benefits that truly improve patients’ lives.


Janik Jaskolski
CEO & Co-Founder LinkedIn

2015

Foundation

70

Employees
(Jan 2021)

24

Nationalities

229 035

Recognised Clinical Data Types and Entities

13

Diseases researched from
various Treatment Areas, incl. Rare Diseases
(Jan 2021) 

17 000 000

Patient Narratives analyzed

Semalytix in the media

Forbes

April 21st, 2021

Forbes AI 30 Germany, Austria, Switzerland 2021 - The list

These 30 start-ups in the field of artificial intelligence (AI) have attracted particular attention in the region of Germany, Austria, switzerland) [...]

Read more


Washington Latest

February 18h, 2021

Semalytix receives € 2 million from NRW.BANK.Venture Fund

As part of an extended Series A financing round, NRW.BANK is investing in Semalytix with its venture fund.

The Bielefeld-based startup has developed the artificial intelligence-based platform “Pharos” for the systematic research of patient needs. The aim is to improve future generations of drugs by recording patients’ treatment experience and uncovering any unknown side effects. The company plans to expand its software, improve performance, and further strengthen its market position with the investment. [...]

Read more


2021

February 17th, 2021

Handelsblatt //Semalytix: AI platform evaluates patient comments

The start-up's AI platform evaluates what patients write about drugs and therapies in forums and social media. The company has now raised fresh capital.
Berlin. For Semalytix CEO Janik Jaskolski, sentences are not just a series of letters; they function according to mathematical laws [...]
[Translated with www.DeepL.com/Translator]
 

Read more

January 21st, 2021

Manager Magazin // How East Westphalia-Lippe became a hotspot for the digital scene

For a long time, the region stood for big middle-class companies and old money: rich, but a little sleepy. Now the province is breaking into the digital modern age.
Torsten Bendlin (51), a single father, business administrator, 17 years with kitchen manufacturer Nolte in Löhne, most recently as head of corporate purchasing, first heard the word pitch six years ago when he was doing his international MBA [...]
[Translated with www.DeepL.com/Translator]

Read more

January 18th, 2021

Press Release // AI startup Semalytix receives € 2 million from NRW.BANK.Venture Fund

As part of an extended Series A financing round, NRW.BANK is investing in Semalytix with its venture fund. The Bielefeld-based startup has developed the artificial intelligence-based platform “Pharos” for the systematic research of patient needs. The aim is to improve future generations of drugs by recording patients’ treatment experience and uncovering any unknown side effects. The company plans to expand its software, improve performance, and further strengthen its market position with the investment. [...]

Read more

January 5th, 2021

Das kommt aus Bielefeld.de // The ear to the net

Artificial intelligence is their métier. "We focus on the pharmaceutical business with the algorithms and tools we develop," says Janik Jaskolski, CEO of Semalytix, a Bielefeld-based startup founded in 2015 and created as a spin-off of the Semantic Computing research group. The goal is to improve treatment methods for people by incorporating the patient perspective or their insights.
[...]
[Translated with www.DeepL.com/Translator]

Read more

2020

November 24th, 2020

Press Release // Corporate Vice President of Bayer Pharmaceuticals becomes advisor to Semalytix

Semalytix announced today that Frank Misselwitz, Corporate Vice President of Bayer Pharmaceuticals, is supporting the company in the role of an advisor […]

Read more

October 30th, 2020

Handelsblatt // Focus wanted

Founders often have good ideas, but limited resources. On the way to a functioning business model, it is also necessary to cope with setbacks.
The lighthouse is beginning to shine: "Pharos" is what the start-up Semalytix has christened its central program [...]
[Translated with www.DeepL.com/Translator]

Read more

August 31st, 2020

TechCruch // Semalytix picks up €4.3M to build the world’s largest patient experience data set

Semalytix, a Bielefeld, Germany-based startup that offers pharmaceutical companies an AI-powered data tool to better understand real-world patient experiences, has raised €4.3 million in Series A funding [...]

Read more

2019

May 24th, 2019

StartupValley Magazine // Have the courage and self-confidence to think big 

Semalytix: Machine Reading in combination with Data Story Telling. Please introduce yourself and the startup Semalytix to our readers! My name is Janik Jaskolski, I am co-founder and managing director of Semalytix. Simply put, we teach computers to read and explain these read digital texts. Our main focus is to make medical content understandable. We transform [...][Translated with www.DeepL.com/Translator]

Read more

May 6th, 2019

deutsche startups.de // “When we started, we were one of the few startups in the region."

The Bielefeld start-up Semalytix is currently working on "important milestones" to reach the planned Series A round. "This includes the next major customers, the achievement of some new developments and internal restructuring that will allow us to move on to the next stage of growth," says co-founder Janik Jaskolski […]
[Translated with www.DeepL.com/Translator]

Read more

January 21rst, 2019

Press Release // Bielefeld-based start-up Semalytix participates in EU research project

Prêt-à-LLOD: Ready-to-use Multilingual Linked Language Data for Knowledge Services across Sectors - this is the name under which a research project was launched at the beginning of 2019 for which the European Commission is providing €3 million under the Horizon 2020 funding line […]

Read more

2018

November 26th, 2018

Forbes // Meet The 100 Most Innovative Startups Of Germany In 2018 (Forbes)

The Hundertis a Berlin-based startup project and print magazine featuring outstanding companies and their founders since 2013. Every issue puts 100 amazing startups in the spotlight and tells their stories […]

Read more

November 26th, 2018

The Hundert // Dark Data Understanding 

Semalytix is a Spin-Off out of Bielefeld University. They move cutting edge research into the business intelligence and competitive intelligence markets to help teams maximize their competitive edge and return on investment. Highlight of the year: Closing Seed-Funding round to accelerate product development and goto-market […]

Read more

November 17th, 2018

Wirtschaftswoche Economy 4.0 // Semalytix brings light into the global pharmaceutical industry 

Mr. Jaskolski, what added value does Semalytix offer the pharmaceutical industry? We are working on using Artificial Intelligence (AI) to explain the global conversation around the core values of the pharmaceutical industry. Our technology is able to develop a human-like understanding of text and thus make complex relationships in large amounts of unstructured data accessible to the user. Our AI-as-a-Service platform combines information from the following sources […]
[Translated with www.DeepL.com/Translator]

Read more

Photos

Semalytix Founders Janik Jaskolski, Matthias Hartung, Philipp Cimiano
Semalytix Pharos Dashboard
Semalytix Co-Founder Janik Jaskolski

Downloads

Logos

SMLTX Logo 2020
LOGO_2020_BLK
favicon2020
SMLTX Logo 2020

Home

Pharos Suite

Company

Team

Careers

Blog

Media

Research

Contact

Meller Str 2 33613 Bielefeld Germany 
Call: +49-521-9145-6127
Email: info@semalytix.com

Court of Registration:
Amtsgericht Bielefeld HRB 41831
VAT ID No.: DE 300921056

Management Board: Janik Jaskolski